Fuad El-Hibri is the founder and chairman of the board of Emergent BioSolutions. Concurrently, Fuad El-Hibri serves on the board of the International Biomedical Research Alliance, which runs the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program.
The (NIH) Oxford-Cambridge Scholars Program brings together top researchers from the United States, the United Kingdom, and Europe to take part in a selective biomedical PhD or MD/PhD training program. Based on the British system, the program allows students to conduct research in areas of interest without taking required formal courses, as the scholars have already gained valuable experience through engagement in research during employment, summer programs, or their undergraduate research programs.
